{"id":20412,"date":"2020-10-14T23:34:00","date_gmt":"2020-10-15T03:34:00","guid":{"rendered":"https:\/\/framinghamsource.com\/?p=20412"},"modified":"2020-10-15T13:39:29","modified_gmt":"2020-10-15T17:39:29","slug":"pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care","status":"publish","type":"post","link":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/","title":{"rendered":"PierianDx &#038; Pillar Biosciences Announce Partnership To Support Precision Cancer Care"},"content":{"rendered":"\n<p><strong>The following is a press release from Pillar Biosciences submitted to SOURCE media through its business wire.<\/strong><\/p>\n\n\n\n<p>***<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;53820&#8243;]<\/strong><\/p>\n\n\n\n<p>NATICK &#8211; PierianDx,  a clinical genomics informatics company, and Pillar Biosciences, anext-generation sequencing clinical oncology company, today, October 14,  announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with its cancer profiling assays. <\/p>\n\n\n\n<p>Under the agreement, PierianDx will integrate the Pillar Biosciences PiVAT\u00ae bioinformatics pipeline in the PierianDx environment to provide users with an accelerated implementation, including assay-specific variant filters, to produce best-in-class clinical genomics reports and enable a complete sample-to-answer solution.<\/p>\n\n\n\n<p>Pillar Biosciences is a clinical cancer diagnostics company located on Michigan Drive in Natick and Shanghai, China.<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;70106&#8243;][broadstreet zone=&#8221;70107&#8243;]<\/strong><\/p>\n\n\n\n<p>Laboratories worldwide use Pillar Biosciences\u2019 assays to detect pivotal genetic variants for cancer and other diseases. Pillar Biosciences\u2019 targeted panels utilize a proprietary enrichment chemistry, SLIMamp\u00ae, that enables rapid, automated amplification of overlapping amplicons in a single tube using minimal sample inputs. Pillar Biosciences\u2019 complementary bioinformatics pipeline, PiVAT<sup>\u00ae<\/sup>, is optimized for efficiency, reducing reflex testing and enabling low-frequency variant calling for every type of variant while consuming limited computing resources. PierianDx provides the Clinical Genomics Workspace\u2122, which consists of intuitive software and a robust clinical Knowledgebase that transforms variant information into a highly-structured and comprehensive physician-ready report.<\/p>\n\n\n\n<p>Streamlining NGS along with clinical genomic interpretation and reporting, especially for sophisticated panels, remains time-consuming and challenging. By packaging the Pillar Biosciences panels with the PierianDx report, the result will be an out-of-the-box clinical genomic report that is optimized for each assay. Furthermore, the solution will be available to customers globally through secure, and in the case of European regions, Global Data Protection Regulation (GDPR)-compliant, cloud instances. As a result, laboratories and healthcare organizations worldwide will have a highly reliable method for providing these tests to enable precision diagnostics and treatments for their patients.<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;59945&#8243;]<\/strong><\/p>\n\n\n\n<p>\u201cThe assays from Pillar Biosciences provide robust detection for all variant types in a simplified workflow,\u201d said Gang Song, PhD, CEO of Pillar Biosciences. \u201cBy optimizing variant filters and integrating with the PiVAT pipeline, PierianDx is streamlining interpretation and reporting, which adds substantial value for our customers.\u201d<\/p>\n\n\n\n<p>Rakesh Nagarajan, MD, PhD and Founder and Chief Technical and Visionary Officer of PierianDx, said \u201cWe are thrilled to provide this support for the Pillar Biosciences assays. As the market shifts to more sensitive assays in the LDT space and leading assay manufacturers seek\u00a0<em>in vitro<\/em>\u00a0diagnostic (IVD) approval, we are committed to addressing challenges that arise from even greater complexity in the interpretation and reporting process.\u201d<\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;59948&#8243;]<\/strong><\/p>\n\n\n\n<p>Founded in 2014 out of Washington University in St. Louis, PierianDx is focused on advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems, laboratories, and patients worldwide. Its industry-leading clinical genomics technologies, CAP and CLIA accredited laboratory, IVD-ready knowledgebase and reporting solution, and expertise deliver the most integrated, trusted, and collaborative approach across the clinical care spectrum. <\/p>\n\n\n\n<p><strong>[broadstreet zone=&#8221;61072&#8243;]<\/strong><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The following is a press release from Pillar Biosciences submitted to SOURCE media through its business wire. *** [broadstreet zone=&#8221;53820&#8243;] NATICK &#8211; PierianDx, a clinical genomics informatics company, and Pillar Biosciences, anext-generation sequencing clinical oncology company, today, October 14, announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":20404,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false},"categories":[9,152,8],"tags":[2629,177,6735,6736],"class_list":["post-20412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","category-natick-source","tag-natick-business","tag-natick-source","tag-pieriandx","tag-pillar-biosciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PierianDx &amp; Pillar Biosciences Announce Partnership To Support Precision Cancer Care - Framingham Source<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PierianDx &amp; Pillar Biosciences Announce Partnership To Support Precision Cancer Care - Framingham Source\" \/>\n<meta property=\"og:description\" content=\"The following is a press release from Pillar Biosciences submitted to SOURCE media through its business wire. *** [broadstreet zone=&#8221;53820&#8243;] NATICK &#8211; PierianDx, a clinical genomics informatics company, and Pillar Biosciences, anext-generation sequencing clinical oncology company, today, October 14, announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Framingham Source\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-15T03:34:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-15T17:39:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"355\" \/>\n\t<meta property=\"og:image:height\" content=\"142\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/\"},\"author\":{\"name\":\"editor\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/person\\\/d95459516e960a3f10c089ebfc8abce4\"},\"headline\":\"PierianDx &#038; Pillar Biosciences Announce Partnership To Support Precision Cancer Care\",\"datePublished\":\"2020-10-15T03:34:00+00:00\",\"dateModified\":\"2020-10-15T17:39:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/\"},\"wordCount\":500,\"publisher\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/pillar.biosciences.natick.jpeg\",\"keywords\":[\"Natick Business\",\"natick Source\",\"PierianDx\",\"Pillar Biosciences\"],\"articleSection\":[\"Business\",\"Health\",\"NATICK SOURCE\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/\",\"name\":\"PierianDx & Pillar Biosciences Announce Partnership To Support Precision Cancer Care - Framingham Source\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/pillar.biosciences.natick.jpeg\",\"datePublished\":\"2020-10-15T03:34:00+00:00\",\"dateModified\":\"2020-10-15T17:39:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/pillar.biosciences.natick.jpeg\",\"contentUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/pillar.biosciences.natick.jpeg\",\"width\":355,\"height\":142},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/2020\\\/10\\\/14\\\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/framinghamsource.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PierianDx &#038; Pillar Biosciences Announce Partnership To Support Precision Cancer Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#website\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/\",\"name\":\"Framingham Source\",\"description\":\"A self-publishing community bulletin board.\",\"publisher\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/framinghamsource.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#organization\",\"name\":\"Framingham Source\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png\",\"contentUrl\":\"https:\\\/\\\/framinghamsource.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png\",\"width\":912,\"height\":300,\"caption\":\"Framingham Source\"},\"image\":{\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/framinghamsource.com\\\/#\\\/schema\\\/person\\\/d95459516e960a3f10c089ebfc8abce4\",\"name\":\"editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g\",\"caption\":\"editor\"},\"description\":\"Susan Petroni is the former editor for SOURCE. She is the founder of the former news site, which as of May 1, 2023, is now a self-publishing community bulletin board. The website no longer has a journalist but a webmaster.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/susan-scully-petroni-8700992\\\/\"],\"url\":\"https:\\\/\\\/framinghamsource.com\\\/index.php\\\/author\\\/editor\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PierianDx & Pillar Biosciences Announce Partnership To Support Precision Cancer Care - Framingham Source","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/","og_locale":"en_US","og_type":"article","og_title":"PierianDx & Pillar Biosciences Announce Partnership To Support Precision Cancer Care - Framingham Source","og_description":"The following is a press release from Pillar Biosciences submitted to SOURCE media through its business wire. *** [broadstreet zone=&#8221;53820&#8243;] NATICK &#8211; PierianDx, a clinical genomics informatics company, and Pillar Biosciences, anext-generation sequencing clinical oncology company, today, October 14, announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in [&hellip;]","og_url":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/","og_site_name":"Framingham Source","article_published_time":"2020-10-15T03:34:00+00:00","article_modified_time":"2020-10-15T17:39:29+00:00","og_image":[{"width":355,"height":142,"url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg","type":"image\/jpeg"}],"author":"editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"editor","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#article","isPartOf":{"@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/"},"author":{"name":"editor","@id":"https:\/\/framinghamsource.com\/#\/schema\/person\/d95459516e960a3f10c089ebfc8abce4"},"headline":"PierianDx &#038; Pillar Biosciences Announce Partnership To Support Precision Cancer Care","datePublished":"2020-10-15T03:34:00+00:00","dateModified":"2020-10-15T17:39:29+00:00","mainEntityOfPage":{"@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/"},"wordCount":500,"publisher":{"@id":"https:\/\/framinghamsource.com\/#organization"},"image":{"@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg","keywords":["Natick Business","natick Source","PierianDx","Pillar Biosciences"],"articleSection":["Business","Health","NATICK SOURCE"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/","url":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/","name":"PierianDx & Pillar Biosciences Announce Partnership To Support Precision Cancer Care - Framingham Source","isPartOf":{"@id":"https:\/\/framinghamsource.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#primaryimage"},"image":{"@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg","datePublished":"2020-10-15T03:34:00+00:00","dateModified":"2020-10-15T17:39:29+00:00","breadcrumb":{"@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#primaryimage","url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg","contentUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg","width":355,"height":142},{"@type":"BreadcrumbList","@id":"https:\/\/framinghamsource.com\/index.php\/2020\/10\/14\/pieriandx-and-pillar-biosciences-announce-partnership-to-support-precision-cancer-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/framinghamsource.com\/"},{"@type":"ListItem","position":2,"name":"PierianDx &#038; Pillar Biosciences Announce Partnership To Support Precision Cancer Care"}]},{"@type":"WebSite","@id":"https:\/\/framinghamsource.com\/#website","url":"https:\/\/framinghamsource.com\/","name":"Framingham Source","description":"A self-publishing community bulletin board.","publisher":{"@id":"https:\/\/framinghamsource.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/framinghamsource.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/framinghamsource.com\/#organization","name":"Framingham Source","url":"https:\/\/framinghamsource.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/framinghamsource.com\/#\/schema\/logo\/image\/","url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2023\/01\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png","contentUrl":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2023\/01\/cropped-cropped-Screen-Shot-2023-01-01-at-4.19.03-PM.png","width":912,"height":300,"caption":"Framingham Source"},"image":{"@id":"https:\/\/framinghamsource.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/framinghamsource.com\/#\/schema\/person\/d95459516e960a3f10c089ebfc8abce4","name":"editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/813d6862cae0c7628091fcd22729e8e0914d381327330afbbd1b2f3cccebe56d?s=96&d=mm&r=g","caption":"editor"},"description":"Susan Petroni is the former editor for SOURCE. She is the founder of the former news site, which as of May 1, 2023, is now a self-publishing community bulletin board. The website no longer has a journalist but a webmaster.","sameAs":["https:\/\/www.linkedin.com\/in\/susan-scully-petroni-8700992\/"],"url":"https:\/\/framinghamsource.com\/index.php\/author\/editor\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/framinghamsource.com\/wp-content\/uploads\/2020\/10\/pillar.biosciences.natick.jpeg","_links":{"self":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts\/20412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/comments?post=20412"}],"version-history":[{"count":2,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts\/20412\/revisions"}],"predecessor-version":[{"id":20415,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/posts\/20412\/revisions\/20415"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/media\/20404"}],"wp:attachment":[{"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/media?parent=20412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/categories?post=20412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/framinghamsource.com\/index.php\/wp-json\/wp\/v2\/tags?post=20412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}